FDA approved new drug bulletin: aprotinin injection (trasylol), tacrolimus (prograf).
D000284:Administration, Oral; D007611:Aprotinin / Q000494:pharmacology / Q000627:therapeutic use*; D004347:Drug Interactions; D006801:Humans; D007262:Infusions, Intravenous; D016559:Tacrolimus / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D007611:Aprotinin; D016559:Tacrolimus